Similar observations were reported by Perego et al., who analyzed the relationship between the cytotoxicity of oxaliplatin and the p53 status of several cisplatin-sensitive and cisplatin-resistant cancer cell lines [133]. The gene discussed is TP53; the disease is cancer.